Guidance for the Primary Care Provider in Identifying Infants With Biliary Atresia by 2-4 Weeks of Life: Clinical

Sanjiv Harpavat1, Susan W Aucott2, Saul J Karpen3

  • 1Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.

Pediatrics
|February 17, 2025
PubMed

Insights

This strategy helps identify infants with biliary atresia early. It uses simple checks at the one-month well-child visit to guide bilirubin testing, potentially reducing liver transplants.

Area of Science:

  • Pediatric Medicine
  • Neonatal Health
  • Gastroenterology

Background:

  • Biliary atresia is a serious condition in infants.
  • Early identification is crucial for better outcomes.
  • Current diagnostic methods can be delayed.

Purpose of the Study:

  • To provide a simple strategy for primary care providers.
  • To facilitate early detection of biliary atresia in infants.
  • To reduce the need for liver transplantation through timely intervention.

Main Methods:

  • Utilizes the "By 1 month" well-child visit (2-4 weeks of life).
  • Involves assessment of infant eye color and stool color.
  • Considers prior laboratory results to guide further testing.

Main Results:

  • Aims to quickly identify infants needing direct or conjugated bilirubin level measurement.
  • Potential to streamline the diagnostic pathway for biliary atresia.
  • Facilitates earlier referral and treatment initiation.

Conclusions:

  • This strategy offers a practical approach for early biliary atresia detection.
  • Improved identification can lead to better patient outcomes.
  • Early intervention may decrease the incidence of liver transplantation in affected infants.